Hosted by:
AT Still University
5850 E. Still Circle, Mesa AZ 85206
Room: Cougar

Monday, Nov. 19th, 2018 5:30 – 7:30pm

REGISTER TODAY:

e-mail: melvin.carter@natus.com or jeanette.fitzke@natus.com

Otoscan is a comprehensive ear scanning solution that provides a new, safe and easy way to make digital impressions for custom in-the-ear pieces such as earmolds and hearing aids. The scanning software transforms ear scans into digital image files that are ready to be used in 3D modeling production.

The human ear is a complex component of the human anatomy. As such, creating a digital scan of the ear which includes a dark and potentially curvy and narrow ear canal can be a significant technical challenge. Otoscan provides a solution to the barriers of a successful ear scan but its application does require a basic understanding of how Otoscan works as well as hands-on practice to master the scanning technique. This course provides the opportunity to address both requirements.

In addition to the validated patient benefits, we will review the overall operational and business benefits that Otoscan can provide to a clinic. For instance, a new workflow to the patient evaluation path could lead to increased business efficiencies and patient satisfaction. Compared to the traditionally passive silicone impression process, digital ear scanning could be converted to an active counseling tool that could help optimize the hearing aid selection and purchase process

As we get further into the course, participants will get to know the different hardware pieces that make up the Otoscan application including the scanner, the scanner cradle, a dedicated Otoscan laptop and a practice ear. In addition, the pAT Still University Otoscan Invitation Nov_2018_FINALarticipants will gain an understanding of how the different Otoscan lasers and cameras work together to create a scan and how these components influence scanning technique. Scanning workflow will also be discussed. In addition to a demo of live ear scanning, a brief overview of the Gaminfied in-depth training software and the applications used to scan and order products will be reviewed.

Learner Outcomes:
1. Explain the patient benefits, in addition, to the operational efficiencies that digitizing the analog silicone earmold impression process can provide for the hearing healthcare provider.
2. Describe how custom hearing devices could help providers differentiate and segment their offerings from over-the-counter options.
3. Describe how Otoscan utilizes two different lasers to obtain a complete and accurate scan of the patient’s ear canal.

0.2 CEUs

AT Still University Otoscan Invitation

Primary Care Update: Challenges of Care

Nov. 29-Dec. 1, 2018

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Dermatology Workshop: Inflammatory Dermatoses

Nov. 29, 2018 | 8 a.m.-11 a.m.

Click MORE for program information and tuition pricing.

Separate registration required. Click here to register for the Big Cedar 2018 | Primary Care Update: Challenges of Care | Nov. 29-Dec. 1, 2018.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Exploring Hot Topics in Primary Care

Jan. 19-27, 2019

Click MORE for program information and tuition pricing.

ROYAL CARIBBEAN – ADVENTURE OF THE SEAS
8-night | Eastern Caribbean
Cruise Departure: Fort Lauderdale, Florida
Ports: Labadee, Haiti; San Juan, Puerto Rico; Philipsburg, St. Maarten; and Basseterre, St. Kitts

*CME program will be conducted the days at sea*

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Laser is changing the way dentistry is viewed and practiced. Join us as we explore the value of laser assisted hygiene and its relationship to tissue healing as well as discuss the patient’s perception and expectations of lasers. In this comprehensive, hands-on clinical workshop participants will learn the adjunctive use of laser as a component of periodontal therapy and as a tool for risk management. Working with simulation exercises, detailed instrumentation photography and video, this course will allow practitioners to build clinical skills, confidence, and an understanding of periodontal treatment protocols using soft tissue dental lasers.

This course includes lecture and hands-on components and is in compliance with Arizona Administrative Code R4-11-601-H. Participants will be eligible to use soft tissue lasers in Arizona clinical practice upon course completion.

Program Objectives:

• Discuss the science of laser wavelengths and their absorption characteristics.
• Discuss the adjunctive use of laser in periodontal therapy and recall risk management.
• Apply clinical techniques and methods associated with laser disinfection and laser sulcular debridement.
• Identify the variables of laser energy protocols as they apply to the treatment of gingivitis, chronic, and aggressive periodontitis.
• Interpret tissue interaction when exposed to “warm” and “hot” laser settings and describe techniques to obtain optimum clinical results.
• Describe the specifics of initiated and bare fiber tip applications.
• Determine clinical decisions and laser treatment protocols.

Meet the Instructor:

Janet Press, RDH, has practiced in general and periodontal dentistry since 1975. Ms. Press received her soft tissue laser training through the Academy of Laser Dentistry (ALD) in 1995 and holds an ALD Fellowship. As a faculty member at the Las Vegas Institute for Advanced Dental Studies, Janet was Codirector of the Dynamic Team and Laser Certification programs. Internationally recognized as an expert in the field of dental hygiene laser education, she provides laser training in the academic environment as well as the private sector. Janet has been named a “Distinguished Dental Professional” by Dentsply International, is a member of the American Dental Hygienists’ Association, the American Academy of Oral Systemic Health, the Academy of Laser Dentistry, and is the owner of 21st Century Dentistry, LLC specializing in dental team communication and clinical education.

Review complete course information (pdf).

Note: This course must be paid in full by credit card at the time of registration. Registration is not complete without full payment. 

A.T. Still University is an ADA CERP recognized provider.

Arizona School of Dentistry & Oral Health is a proud member of the Association for Continuing Dental Education. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. A.T. Still University Arizona School of Dentistry & Oral Health designates this activity for 3 continuing education credits.

Sponsored by the Orthopedic Physical Therapy Residency program at A.T. Still University in conjunction with the Physical Therapy Department in the Arizona School of Health Sciences.

The Orthopedic Physical Therapy Residency program is accredited through the American Board of Physical Therapy Residency & Fellowship Education (ABPTRFE).

Course Instructor: Todd S. Ellenbecker, PT, DPT, MS, OCS, SCS, CSCS, USPTA

Course Description:

This 1 day lecture and lab course is designed to provide the clinician with an advanced understanding of the anatomy and biomechanics of the shoulder complex, to provide the framework for the development of rehabilitation programs for shoulder conditions. Detailed descriptions of clinical examination methods and hands-on lab time are included. The focus of the course will be on rehabilitation following surgery, and current evidence in the assessment of the scapula and shoulder mobility.

Course Objectives:

Following completion of the course the participant will be able to:

• Describe key concepts related to the anatomy of the shoulder
• Describe key concepts related to the biomechanics of the shoulder
• Understand the force couples of the glenohumeral and scapulo-thoracic joints and apply these concepts in rehabilitation of patients with shoulder conditions
• Describe the current evidence guiding rehabilitation for glenohumeral joint arthritis, shoulder arthroplasty, massive rotator cuff tears, and superior capsule reconstruction
• Describe current concepts in evaluation of the scapula in shoulder rehabilitation
• Describe current concepts for evaluating shoulder mobility
• Understand criterion for return to play following shoulder rehabilitation

CEU: Participants are awarded .8 CEUs or 8 contact hours at the end of the course.

Cost: $195; $160 for ATSU alumni and current Clinical Instructors

ATSU Physical Therapy Department is qualified to provide physical therapist continuing education courses and activities according to the Arizona State Board of Physical Therapy (Rule R4-24-402).

CEU courses and other post-professional programs offered at ATSU are not associated with the CAPTE accredited residential Doctor of Physical Therapy program.

Therapeutic Exercise – PNF for the Orthopedic Patient by Michael Moore, PT; Tim Fearon, PT, DPT

To register for this course, click here

Course Description
The purpose of this course is to bridge the gap from passive intervention to patient active rehabilitation and self management. Using the principles of PNF applied to the Orthopedic patient you will gain skill in designing truly therapeutic exercise from the early stage of an episode of care to discharge and beyond.

Day 1 will be taught by Michael Moore and will focus on applying PNF principles and techniques for the patient who is ready to transfer from passive intervention to patient active therapist guided techniques. You will develop skills in leveraging the patients neuromuscular system to give them the ability to change their own symptoms preparing for self directed exercise.

Day 2 will be taught by Tim Fearon and will focus on the transition from Day 1’s activities to truly patient directed activities for management of their own symptoms enabling them to drive towards independence

Primary Care Update

Feb. 28-Mar. 2, 2019

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

DIN-1: Foundations of Dynamic Integrative Needling Systems (DINS)

To register for this course, click here

The Hobbs Masters Needling Series begins with a 27-hour foundational education course tailored for clinicians new to dry needling. Though essential for beginners, experienced practitioners will find the material informative and refreshing, helping to focus and simplify their practice while improving patient outcomes.

This 3-day course is supplemented with online modules carefully developed to maximize delivery of live, 90% hands-on instruction. Practitioners will learn clinically reasoned, evidence-informed approaches of all major regions of the body, including the spine and both upper and lower quarters, for a wide range of musculoskeletal disorders. This will provide the busy clinician the requisite instruction necessary to treat the most common conditions encountered in daily clinical practice without the need to take multiple courses.

For a broader foundational understanding, participants will be instructed not only in needling superficially and deep within muscles (i.e., trigger point dry needling) but will also learn proper periosteal and connective tissue needling techniques for many conditions. Additionally, participants will learn how to integrate peripheral, spinal segmental and central needling approaches within a clinical reasoning framework.

This course will focus on the therapeutic effects of manual dry needle manipulation, with emphasis placed on safe needle handling, relevant anatomical considerations for each region, and appropriate selection of sites to needle on the body. Clinicians will also gain skill in appropriate dosing of dry needling to allow for optimal effectiveness and maximal patient comfort. Through the lens of modern pain science, clinicians will be educated on the potent anti-nociceptive effects that dry needling can offer to patients with painful musculoskeletal disorders.

Objectives:

By the end of this course participants will be able to:

Correctly identify 10 contraindications and 10 precautions to the use of dry needling.
Demonstrate safe DINS handling techniques and patient positioning for 5 axial spine techniques.
Demonstrate safe DINS handling techniques and patient positioning for 5 extremity techniques.
Correctly describe the appropriate management of 5 adverse events that may occur in association with DINS.
Orally explain the current theoretical neurophysiological mechanisms of DINS from the periphery to the cortex.
Appropriately defend the integration of DINS into the management of a given patient with a neuromusculoskeletal condition.
Course Developer/Owner:

Jonathan Hobbs, MSc, MCSP, FHEA, AACP Chairman (UK)
Accredited Course Instructors:

Dr. Sean Flannagan, PT, DPT, MAACP (UK)
Dr. Matthew Grubb, PT, DPT, MS, FAAOMPT, MAACP (UK)
Dr. Rachel Grubb, PT, DPT, FAAOMPT, MAACP (UK)

Sponsored by the Orthopedic Physical Therapy Residency program at A.T. Still University  in conjunction with the Physical Therapy Department in the Arizona School of Health Sciences.

The Orthopedic Physical Therapy Residency program has applied for accreditation to the American Board of Physical Therapy Residency & Fellowship Education (ABPTRFE).

Course Instructor: Chris Powers, PhD, PT, FACSM, FAPTA

Contact hours: Participants are awarded 8 contact hours at the end of the course.

Cost: $195;  $160 for ATSU Alumni and current Clinical Instructors

ATSU Physical Therapy Department is qualified to provide physical therapist continuing education courses and activities according to the Arizona State Board of Physical Therapy (Rule R4-24-402).

CEU courses and other post-professional programs offered at ATSU are not associated with the CAPTE accredited residential Doctor of Physical Therapy program.

The Credentialed Clinical Instructor Program Level 2 (CCIP Level 2), formerly the Advanced CCIP) is designed for physical therapists and physical therapist assistants who want to further develop their clinical teaching skills and construct a clinical curriculum. Using a case-based and interactive approach to education, this program will provide participants with the essential knowledge and skill to more effectively teach and mentor students in the context of a doctoring profession, across core areas of contemporary professional education and clinical practice that foster best clinical teaching. The program’s unique philosophy and design both applies and goes beyond the concepts of the APTA Credentialed Clinical Instructor Level 1 Program (CCIP Level 1) to l enable clinical educators to achieve the best outcomes for student learning.

The program is divided into three distinct parts:

1. Pre-course assignments that include reading four articles and completing three of the online Professionalism Modules.
2. Advanced clinical instructor education via an interactive face-to-face course format that is appropriate to all physical therapist clinical educators;
3. Assessment (credentialing) of curricula outcomes through an Assessment Center to apply information from the ACCIP.

These components are used together to first provide, and then assess, the knowledge and skill identified as essential for Advanced CIs.

Intended audience: Physical Therapists or Physical Therapist Assistants who have completed the APTA Credentialed Clinical Instructor Level 1 Program (CCIP Level 1) and have supervised at least one student in clinical practice, overseen the supervision of at least one student in clinical practice, or have been actively involved in student learning and education since becoming credentialed. As with the CCIP Level 1, eligible clinicians from other health care professions are welcome to participate and can earn CEUs for the program, although they will not be APTA credentialed.

Firm registration deadline: February 27, 2019

Course Description: 

The goal of this one-day course is to demystify the processes of physical therapy examination, evaluation and intervention in the coprehensive care of individuals with multiple sclerosis (MS). The course will cover the most current evidence and practice in the management of MS. The course will involve lecture, discussion, patient case study and live demonstration of strategies for implementation in the clinic.

Course Objectives:

At completion of this course, the participant will be able to:

• Describe the etiology, epidemiology, pathophysiology, signs and symptoms, diagnosis, and course of multiple sclerosis (MS).
• Describe elements of the medical management of patients with MS.
• Identify and describe the examination procedures used to inform the evaluation of patients with MS to establish the physical therapy diagnosis, prognosis, and plan of care.
• Describe the role of the physical therapist in the management of persons with MS in terms of direct interventions and patient/client-related instruction to maximize function and quality of life.

Course Instructors:

Maria Rundell, PT, DPT, NCS, MSCS

National MS Society Representative

Registration Fees: $195.00 or $160.00 for ATSU Alumni, Clincal Instructors with ATSU students, or groups of 3 or more from one organization.

Contact Hours: 8 Contact Hours or .8 CEU’s

2019 ATSU Alaska CME/CE Cruise

June 14-21, 2019

Click MORE for program information and tuition pricing.

ROYAL CARIBBEAN – OVATION OF THE SEAS | 7-night | Alaska Glacier Cruise
Cruise Departure: Seattle, Washington
Itinerary: Seattle, Washington | Alaska Inside Passage | Juneau, Alaska | Skagway, Alaska | Endicott Arm & Dawes Glacier |
                     Victoria, British Columbia | Seattle, Washington

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• • • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
    • Limit content to evidence with no recommendations
    • Introduction of a debate format with an unbiased moderator (point-counterpoint)
    • Inclusion of moderated panel discussion
    • Publication of a parallel or rebuttal article for an article that is felt to be biased
    • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
    • Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660.626.2232 for assistance.

Sponsored by the Orthopedic Physical Therapy Residency program at A.T. Still University  in conjunction with the Physical Therapy Department in the Arizona School of Health Sciences.

The Orthopedic Physical Therapy Residency program is accredited by the American Board of Physical Therapy Residency & Fellowship Education (ABPTRFE).

Course Instructor: Colin Rigney, PT, DPT, OCS, RMSK and Wayne Smith, PT, DPT. ATC, SCS, RMSK

Course Description: Do you want to know the what medical teams at the Olympics, Professional and Collegiate teams, even the International Space Station, are using to give them an edge in treatment? A.T. Still University is presenting an introductory two-part seminar in clinical applications of using musculoskeletal ultrasound imaging. The morning session will cover introduction to musculoskeletal ultrasound imaging and pathology as well as a live demonstration of selected anatomical sites. The afternoon session will include lives scanning and lectures on the US instrumentation and physics, image optimization, how to scan commonly treated joints and the lumbar spine, identification of tendons, nerves, muscles, and ligaments.

Course Objectives:

1. Introduce the participants to ultrasound musculoskeletal images
2. Explain US physics and instrumentation of US equipment.
3. Identify when Sonography is indicated to assist in managing common conditions.
4. Understand what information can be derived from Sonography.
5. Be able to perform an ultrasound assessment on selected anatomical structures.

CEU: Participants are awarded 0.7 CEUs or 7 contact hours at the end of the course.

Cost: $175 APTA members;  $150 for non ATSU Alumni and Clinical Instructors

ATSU Physical Therapy Department is qualified to provide physical therapist continuing education courses and activities according to the Arizona State Board of Physical Therapy (Rule R4-24-402).

CEU courses and other post-professional programs offered at ATSU are not associated with the CAPTE accredited residential Doctor of Physical Therapy program.

Primary Care Update

Aug. 2-4, 2019

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Sponsored by the Orthopedic Physical Therapy Residency program at A.T. Still University  in conjunction with the Physical Therapy Department in the Arizona School of Health Sciences.

The Orthopedic Physical Therapy Residency program is accredited by the American Board of Physical Therapy Residency & Fellowship Education (ABPTRFE).

Course Instructor: Kathy Petkovsky, PT, CHT and the Orthopedic Physical Therapy Residency faculty

Course Description: Featured topics for the general orthopedic clinical practice, including tendinopathies, peripheral nerve entrapments, and fractures, this course emphasizes clinical reasoning developing the participants’ skills that can be applied Monday morning in the clinic. This course includes ample lab time with a strong instructor participant ratio.

Course Objectives:

At the conclusion of this course, participants will be able to:

1. Assess the elbow, wrist, and hand regions for common injuries and conditions.

2. Review current best evidence for examination and management of conditions in the region of the elbow, wrist, and hand.

3. Apply improved examination and intervention strategies.

CEU: Participants are awarded .7 CEUs or 7 contact hours at the end of the course.

Cost: $175; $150 for ATSU alumni and current Clinical Instructors

ATSU Physical Therapy Department is qualified to provide physical therapist continuing education courses and activities according to the Arizona State Board of Physical Therapy (Rule R4-24-402).

CEU courses and other post-professional programs offered at ATSU are not associated with the CAPTE accredited residential Doctor of Physical Therapy program.

Osteopathic Approach to Primary Care

Oct. 10-12, 2019

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.